Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT) — Stella

Recruiting

Back to Pulmonary Hypertension trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Pakistan

Sindh Institute of Cardiovascular Diseases, Hyderābād, Sindh

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Sindh Institute of Cardiovascular Diseases

Collaborators

National Institute of Cardiovascular Diseases

Enrollment target

~100 participants

Started

August 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov